Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib is effective and safe for treating severe alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.